Terug
37
Ook genoteerd als
MZHOF
OTC
Dagbereik
€ 7,70
€ 7,89
52-Weeksbereik
€ 4,04
€ 10,28
Volume
7.143.659
50D / 200D Gem.
€ 8,63
/
€ 6,99
Vorige Slotkoers
€ 7,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (854 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 10,3 |
| P/B | 0,0 | 1,1 |
| ROE % | 8,6 | 11,7 |
| Net Margin % | 10,3 | 16,8 |
| Rev Growth 5Y % | 31,4 | 11,6 |
| D/E | 5,8 | 0,5 |
Koersdoel Analisten
Hold
€ 10,00
+28.0%
Forward K/W
0,1
Forward WPA
€ 96,69
WPA Groei (sch.)
+0,0%
Omzet Sch.
3200 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 151,99
€ 142,54 – € 159,99
|
2500 B | 1 |
| FY2029 |
€ 143,22
€ 134,31 – € 150,76
|
4900 B | 1 |
| FY2028 |
€ 126,33
€ 118,47 – € 132,98
|
4100 B | 1 |
Insider Trading Activity
Buy ratio (90d)
100.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 |
HELMETAG CARL
Director
|
other | 3.200 | € 26,25 | € 84.000 |
| Jan 30, 2026 |
Kundu Sourav
Sr VP, Dev. & Mfg.
|
grant | 8.270 | — | — |
| Jan 13, 2026 |
VIRTUE ROBERT A
CEO
|
buy | 2.500 | € 6,32 | € 15.800 |
| Jan 7, 2026 |
RICHARDSON BRADLEY C
Director
|
buy | 2.000 | € 6,50 | € 13.009 |
| Dec 16, 2025 |
HELMETAG CARL
Director
|
sell | 1.000 | € 44,99 | € 44.990 |
| Oct 17, 2025 |
VIRTUE DOUGLAS A
Executive Vice President
|
buy | 13.022 | € 7,34 | € 95.581 |
| Oct 16, 2025 |
VIRTUE ROBERT A
CEO
|
buy | 5.000 | € 6,96 | € 34.800 |
| Aug 28, 2025 |
SMITH BRIAN TRAVIS
EVP, AFP, Mfg., WWEC & HSE
|
other | 2.200 | € 68,18 | € 149.996 |
| Aug 27, 2025 |
SMITH BRIAN TRAVIS
EVP, AFP, Mfg., WWEC & HSE
|
buy | 1.750 | € 68,34 | € 119.595 |
| Aug 5, 2025 |
ONEIL DAVID A
President & CEO
|
other | 10.000 | € 13,61 | € 136.100 |
| Jul 14, 2025 |
VIRTUE ROBERT A
CEO
|
buy | 2.000 | € 8,15 | € 16.300 |
| Jun 17, 2025 |
Lind Robert R
Director
|
grant | 6.134 | € 8,14 | € 49.931 |
| Jun 17, 2025 |
LEVRA CRAIG L
Director
|
grant | 4.601 | € 8,14 | € 37.452 |
| Jun 17, 2025 |
RICHARDSON BRADLEY C
Director
|
grant | 6.134 | € 8,14 | € 49.931 |
| Jun 17, 2025 |
Winkler Agnieszka
Director
|
grant | 6.134 | € 8,14 | € 49.931 |
| Jun 6, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 216 | € 563,11 | € 121.632 |
| Jun 5, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 215 | € 560,70 | € 120.551 |
| Jun 4, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 215 | € 552,07 | € 118.695 |
| Jun 3, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 215 | € 550,68 | € 118.396 |
| Jun 2, 2025 |
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
sell | 215 | € 549,06 | € 118.048 |
Belangrijkste Punten
Revenue grew 31,36% annually over 5 years — strong growth
Earnings grew 30,40% over the past year
Debt/Equity of 5,83 — high leverage
Negative free cash flow of -4,17T
P/E of 0,11 — trading at a low valuation
PEG of 0,38 suggests growth is underpriced
Groei
Revenue Growth (5Y)
31,36%
Revenue (1Y)9,47%
Earnings (1Y)30,40%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
8,57%
ROIC1,25%
Net Margin10,30%
Op. Margin13,84%
Veiligheid
Debt / Equity
5,83
Current Ratio0,39
Interest Coverage0,24
Waardering
P/E Ratio
0,11
P/B Ratio0,01
EV/EBITDA-9,66
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,47% | Revenue Growth (3Y) | 32,65% |
| Earnings Growth (1Y) | 30,40% | Earnings Growth (3Y) | 26,25% |
| Revenue Growth (5Y) | 31,36% | Earnings Growth (5Y) | 17,09% |
| Profitability | |||
| Revenue (TTM) | 8,60T | Net Income (TTM) | 885,43B |
| ROE | 8,57% | ROA | 0,31% |
| Gross Margin | 41,79% | Operating Margin | 13,84% |
| Net Margin | 10,30% | Free Cash Flow (TTM) | -4,17T |
| ROIC | 1,25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5,83 | Current Ratio | 0,39 |
| Interest Coverage | 0,24 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 0,11 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | 0,38 |
| EV/EBITDA | -9,66 | Dividend Yield | 0,03% |
| Market Cap | 96,46B | Enterprise Value | -11,50T |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8,60T | 7,86T | 4,89T | 2,84T | 2,89T |
| Net Income | 885,43B | 678,99B | 555,53B | 530,48B | 471,02B |
| EPS (Diluted) | 70,04 | 53,58 | 43,84 | 41,85 | 37,15 |
| Gross Profit | 3,59T | 2,86T | 2,58T | 2,28T | 2,26T |
| Operating Income | 1,19T | 955,04B | 778,96B | 603,87B | 652,16B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 283,32T | 278,67T | 254,26T | 237,07T | 225,59T |
| Total Liabilities | 272,80T | 268,36T | 245,05T | 227,87T | 216,22T |
| Shareholders' Equity | 10,44T | 10,23T | 9,13T | 9,08T | 9,26T |
| Total Debt | 60,89T | 58,95T | 45,34T | 40,96T | 40,31T |
| Cash & Equivalents | 72,48T | 72,97T | 67,15T | 51,36T | 47,98T |
| Current Assets | 86,19T | 72,97T | 67,15T | 51,36T | 75,20T |
| Current Liabilities | 221,32T | 216,38T | 197,18T | 182,29T | 178,12T |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#286 of 618
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026